Role of protein kinase C on the alteration of retinal endothelin-1 in streptozotocin-induced diabetic rats

Experimental Eye Research

Volumn 81, Issue 2, 2005, Pages 200-206

  Zhu, Qi ^a   Xu, Xun ^a   Xia, Xin ^a   Gu, Qing ^a   Ho, Patrick C P ^b  

^a SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

^b 8/F Kailey Tower ^*  (Hong Kong)

Author keywords

Diabetic retinopathy; Endothelins; Protein kinase C

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; ENDOTHELIN 1; ENDOTHELIN 3; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; PROTEIN KINASE C; TRYPSIN;

ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; CYTOSOL; DIABETIC RETINOPATHY; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA; RETINA BLOOD VESSEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; STREPTOZOCIN DIABETES;

ANIMALS; CELL MEMBRANE; CYTOSOL; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; ENDOTHELINS; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; INDOLES; MALE; MALEIMIDES; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; RETINA; RETINAL VESSELS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 23144456713     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2005.01.025     Document Type: Article

References (27)

1. G. Ak, S. Buyukberber, A. Sevinc, H.M. Turk, M. Ates, R. Sari, H. Savli, and A. Cigli The relation between plasma endothelin-1 levels and metabolic control, risk factors, treatment modalities, and diabetic microangiopathy in patients with Type 2 diabetes mellitus J. Diabetes Complications 15 2001 150 157
2. M. Awazu, R.E. Parker, B.R. Harvie, I. Ichikawa, and V. Kon Down-regulation of endothelin-1 receptors by protein kinase C in streptozotocin diabetic rats J. Cardiovasc. Pharmacol. 17 1991 S500 S502
3. S.E. Bursell, A.C. Clermont, T. Shiba, and G.L. King Evaluating retinal circulation using video fluoresce in angiographies in control and diabetic rats Curr. Eye Res. 11 1992 287 295
4. S.E. Bursell, A.C. Clermont, B.T. Kinsley, D.C. Simonson, L.M. Aiello, and H.A. Wolpert Retinal blood flow changes in patients with insulin-dependent diabetes mellitus and no diabetic retinopathy Invest. Ophthalmol. Vis. Sci. 37 1996 886 897
5. S.E. Bursell, C. Takagi, A.C. Clermont, H. Takagi, F. Mori, H. Ishii, and G.L. King Specific retinal diacylglycerol and protein kinase C beta isoform modulation mimics abnormal retinal hemodynamics in diabetic rats Invest. Ophthalmol. Vis. Sci. 38 1997 2711 2720
6. S. Chen, M.D. Apostolova, M.G. Cherian, and S. Chakrabarti Interaction of endothelin-1 with vasoactive factors in mediating glucose-induced increased permeability in endothelial cells Lab. Invest. 80 2000 1311 1321
7. M.V. Ciarla, A. Bocciarelli, S. Di Gregorio, A. Tordi, P. Cotroneo, G. Marra, G. Ghirlanda, and R. Strom Autoantibodies and endothelial dysfunction in well-controlled, uncomplicated insulin-dependent diabetes mellitus patients Atherosclerosis 158 2001 241 246
8. D. Deng, T. Evans, K. Mukherjee, D. Downey, and S. Chakrabarti Diabetes-induced vascular dysfunction in the retina: role of endothelins Diabetologia 42 1999 1228 1234
9. T. Emori, Y. Hirata, K. Ohta, M. Shichiri, and F. Marumo Secretory mechanism of immunoreactive endothelin in cultured bovine endothelial cells Biochem. Biophys. Res. Commun. 160 1989 93 100
10. T. Evans, D.X. Deng, K. Mukherjee, D. Downey, and S. Chakrabarti Endothelins, their receptors, and retinal vascular dysfunction in galactose-fed rats Diabetes. Res. Clin. Pract. 48 2000 75 85
11. G.T. Feke, S.M. Buzney, H. Ogasawara, N. Fujio, D.G. Goger, N.P. Spack, and K.H. Gabbay Retinal circulatory abnormalities in type 1 diabetes Invest. Ophthalmol. Vis. Sci. 35 1994 2968 2975
12. S. Higashi, A.C. Clermont, V. Dhir, and S.E. Bursell Reversibility of retinal flow abnormalities is disease-duration dependent in diabetic rats Diabetes 47 1998 653 659
13. R.L. Hopfner, and V. Gopalakrishnan Endothelin:emerging role in diabetic vascular complications Diabetologia 42 1999 1383 1394
14. I. Idris, S. Gray, and R. Donnelly Protein kinase C activation: isozyme-specific effects on metabolism and cardiovascular complications in diabetes Diabetologia 44 2001 659 673
15. I. Idris, S. Gray, and R. Donnelly Protein kinase C-beta inhibition and diabetic microangiopathy: effects on endothelial permeability responses in vitro Eur. J. Pharmacol. 485 2004 141 144
16. H. Ishii, M.R. Jirousek, D. Koya, C. Takagi, P. Xia, A. Clermont, S.E. Bursell, T.S. Kern, L.M. Ballas, W.F. Heath, L.E. Stramm, E.P. Feener, and G.L. King Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor Science 272 1996 728 731
17. D. Koya, and G.L. King Protein kinase C activation and the development of diabetic complications Diabetes 47 1998 859 866
18. M.W. MacCumber, and S.A. D'Anna Endothelin receptor-binding subtypes in the human retina and choroid Arch. Ophthalmol. 112 1994 1231 1235
19. F. Mori, G.L. King, A.C. Clermont, D.K. Bursell, and S.E. Bursell Endothelin-3 regulation of retinal hemodynamics in nondiabetic and diabetic rats Invest. Ophthalmol. Vis. Sci. 41 2000 3955 3962
20. J.Y. Park, N. Takahara, A. Gabriele, E. Chou, K. Naruse, K. Suzuma, T. Yamauchi, S.W. Ha, M. Meier, C.J. Rhodes, and G.L. King Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation Diabetes 49 2000 1239 1248
21. V. Patel, S. Rassam, R. Newsom, J. Wiek, and E. Kohner Retinal blood flow in diabetic retinopathy BMJ 305 1992 678 683
22. T. Shiba, T. Inoguchi, J.R. Sportsman, W.F. Heath, S. Bursell, and G.L. King Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation Am. J. Physiol. 265 1993 E783 E793
23. C. Takagi, S.E. Bursell, Y.W. Lin, H. Takagi, E. Duh, Z. Jiang, A.C. Clermont, and G.L. King Regulation of retinal hemodynamics in diabetic rats by increased expression and action of endothelin-1 Invest. Ophthalmol. Vis. Sci. 37 1996 2504 2518
24. X. Xu, Z. Li, D. Luo, Y. Huang, J. Zhu, X. Wang, H. Hu, and C.P. Patrick Exogenous advanced glycosylation end products induce diabetes-like vascular dysfunction in normal rats: a factor in diabetic retinopathy Graefe's. Arch. Clin. Exp. Ophthalmol. 241 2003 56 62
25. X. Xu, Q. Zhu, X. Xia, S. Zhang, Q. Gu, and D. Luo Blood-retinal barrier breakdown induced by activation of protein kinase C via vascular endothelial growth factor in streptozotocin-induced diabetic rats Curr. Eye Res. 28 2004 251 256
26. Y. Yamada, and M. Yokota Effects of protein kinase C activation and inhibition on endothelin-1 release from human aortic and pulmonary artery endothelial cells: comparison with effects on bovine endothelin-1 and human prostaglandin I2 release Am. J. Hypertens. 10 1997 32 42
27. T. Yokota, R.C. Ma, J.Y. Park, K. Isshiki, K.B. Sotiropoulos, R.K. Rauniyar, K.E. Bornfeldt, and G.L. King Role of protein kinase C on the expression of platelet-derived growth factor and endothelin-1 in the retina of diabetic rats and cultured retinal capillary pericytes Diabetes 52 2003 838 845